Quectel Introduces New 5G, 4G, Wi-Fi and LoRa IoT Antennas to Complement Its Industry Leading Module Portfolio and Ease Development Process for Customers
Quectel Wireless Solutions, a global IoT solutions provider, today announces the launch of a series of new antennas to further expand the global antenna offering for Quectel customers. The new antennas include the YECT005W1A and YECT004W1A ultra-wide band 5G antennas, the YEMN302Q1A combo antenna series, the YECT028W1A 5G and YECT003W1A 4G antennas, the YFNF915F3AM and YFNF868F3AM LoRa antennas, the YFBC001WWA Wi-Fi antenna and the YFGC007E3A GNSS antenna.
“We are delighted to introduce the latest additions to our antenna portfolio,” commented Norbert Muhrer, President and CSO, Quectel Wireless Solutions. “We continually work to ensure that our range of antenna products complement our expansive module range and meet our customer requirements. Our antennas are optimized and pre-tested with our module portfolio, making the design, integration and testing process faster and easier for our customers.”
The YECT004W1A and YECT005W1A ultra-wide band 5G antennas provide broad coverage from 600–6000MHz while offering backward compatibility to support 4G, 3G, and 2G networks, as well as LTE Cat M and narrowband IoT (NB-IoT). The antenna is terminated with an SMA male connector and is ideal for applications requiring discrete installation. This low-profile, terminal-mount, omni-directional antenna is easy to install, with maximum durability assured by its PC + ABS enclosure. Both antennas measure 135mm × 15.6mm × 13mm, while the YECT004W1A version is an IP67 rated product.
The YEMN302Q1A combo antenna series is capable of integrating a variety of antennas, including 5G, 4G, GNSS, and Wi-Fi antennas, to support communication functions such as 5G MIMO, 4G, GNSS, and Wi-Fi. These antenna units can be mounted on device surfaces using screws, adhesive, or other methods, and support multiple connector types and cable lengths. This series offers a more flexible and reliable high-performance antenna solution for outdoor applications.
The YECT028W1A external 5G antenna covers 5G NR Sub-6GHz frequency bands and is compatible with 4G/3G/2G/LPWA bands. Featuring high efficiency and gain, it is an ideal omni-directional antenna solution to ensure high-speed data transmission. The YECT003W1A external 4G antenna covers main 4G LTE bands and is compatible with 3G/2G/LPWA bands as well.
The YFNF915F3AM and YFNF868F3AM LoRa antennas are compatible with Quectel’s industrial, scientific & medical (ISM) range, making them ideal for smart metering, remote monitoring and telematics applications. The YFNF915F3AM antenna measures 120.2mm × 25mm and provides coverage from 910–930MHz, while the YFNF868F3AM antenna measures 70mm × 40mm and provides coverage from 863–870MHz. Both antennas are supplied with a 150mm cable, terminated with IPEX MHF 1 connector, and is available with customized cable lengths and connectors.
The Quectel YFBC001WWA is a compact, SMT mountable ceramic chip antenna designed for Wi-Fi applications. Measuring a mere 1.6mm x 0.8mm x 0.4mm, it's perfect for devices with limited space, such as Wi-Fi, WLAN, BT, Zigbee, and 802.11 terminals.
The YFGC007E3A GNSS Antenna is a compact unit featuring a PCB and ceramic buckle mount design. Optimized for GNSS L1 and L5 frequencies, it measures 50mm by 50mm by 14.5mm and operates within the 1164-1189MHz and 1559-1606MHz bands. An IPEX MHF 1 connector completes the package.
Quectel also provides global regional antenna support and offers customized antenna design and testing services utilizing the latest technologies and materials to achieve high-performance wireless networking. Additionally, Quectel supports customers in ensuring that their antennas comply with the necessary certification and network approval requirements for their devices.
Quectel is currently exhibiting at MWC Las Vegas. Schedule a meeting to find out more about the Quectel range of products.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,600 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241009079125/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AwardFares Launches Intelligent New Alert System for Award Flight Availability5.8.2025 08:00:00 CEST | Press release
AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/ AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights. The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before. Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on
Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy5.8.2025 02:02:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass’ permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. “Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,” said Venture Global CEO Mike Sabel. Calcasieu Pass, Venture Global’s first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company’s second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global’s third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, re
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain4.8.2025 22:01:00 CEST | Press release
– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint –– Treatment with VX-993 was generally safe and well tolerated, with safety profile similar to placebo arm – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, randomized, double-blind, placebo-controlled dose-ranging study evaluating the safety and efficacy of its investigational selective NaV1.8 pain signal inhibitor, VX-993, in treating acute pain after bunionectomy surgery. Treatment with VX-993 did not result in a statistically significant improvement on the primary endpoint of the time-weighted Sum of the Pain Intensity Difference from 0 to 48 hours (SPID48) compared to placebo. VX-993 was generally safe and well tolerated. Most adverse events (AEs) were mild to moderate, and there were no serious adverse events (SAEs) related to VX-993. Based on these results, Vertex will not progress
TOURISE Announces Cross-Sector Advisory Board to Champion Bold New Platform Rewriting the Rules of Tourism4.8.2025 20:53:00 CEST | Press release
Leaders from World Travel & Tourism Council (WTTC), Global Sustainable Tourism Council, Amadeus, TikTok, Six Senses, Cirque du Soleil, Turismede Barcelona, Liberty International, Wagonlit Travel, Once Billion Happy, the Saudi Tourism Authority (STA), and the Riyadh School of Tourism and Hospitality at the helm of TOURISE Advisory Board Formation of the Advisory Board reinforces TOURISE’s dedication to driving cross-sector global collaboration Advisory Board shape TOURISE summit agenda, ensuring high-impact global issues such as equity, geographical representation and sectoral diversity are in spotlight TOURISE, the bold new global tourism platform, has announced the members of its cross-sector Advisory Board, a powerhouse of industry titans guiding TOURISE’s strategic direction and shaping the agenda of the inaugural global summit taking place in Riyadh from 11-13 November, 2025. TOURISE is where cross-sector convergence begins, a platform where leaders and visionaries debate, collabor
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe4.8.2025 20:38:00 CEST | Press release
Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA’s IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical’s mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804524652/en/ Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study Dr. Samin Sharma enrolled the first patient at New York’s Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom